Characterization of O-Glycosylation and N-Glycosylation in Bispecific Antibodies and Its Importance in Therapeutic Antibody Development
Open Access
- 13 October 2025
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (10) , 1538
Abstract
Background/Objectives: This study comprehensively characterized the O- and N-glycosylation profiles of bispecific antibodies (BsAbs) via advanced analytical techniques to evaluate their structural and functional implications. Methods: High-resolution MS revealed O-xylosylation at Ser468 within the (G4S)4 linker peptide, which was identified as xylose with a molecular weight of 132.042 Da. HILIC-HPLC analysis of N-glycosylation revealed glycan species engineered to eliminate Fc effector functions. O-glycosylation analysis via β-elimination followed by high-performance anion-exchange chromatography with pulsed amperometric detection (HPAEC-PAD) identified xylose as the predominant glycan. Results: O-xylosylation does not affect the binding of BsAbs to either antigen Programmed Death-1 (PD-1) or Vascular Endothelial Growth Factor (VEGF). Notably, O-xylosylation interactions with mannose receptor represent the first discovery highlighting potential immunomodulatory roles. Conclusions: This study highlights the critical importance of monitoring comprehensive glycosylation characterization during the development of BsAb with (G4S)n linkers to ensure optimal therapeutic efficacy, safety, and reduced immunogenic potential.Keywords
Funding Information
- State Key Laboratory of Drug Regulatory Science Project (2025SKLDRS0318)
This publication has 43 references indexed in Scilit:
- Back2Basics: animal lectins: an insight into a highly versatile recognition proteinJournal of Proteins and Proteomics, 2022
- Designing antibodies as therapeuticsCell, 2022
- N-Glycosylation of monoclonal antibody therapeutics: A comprehensive review on significance and characterizationAnalytica Chimica Acta, 2022
- In-depth site-specific O-Glycosylation analysis of therapeutic Fc-fusion protein by electron-transfer/higher-energy collisional dissociation mass spectrometryBiologicals, 2019
- Structural Basis of Protein Asn-Glycosylation by Oligosaccharyltransferases2018
- Regulation of antibody effector functions through IgG Fc N-glycosylationCellular and Molecular Life Sciences, 2016
- Phase 1b study of otlertuzumab (TRU-016), an anti-CD37 monospecific ADAPTIR™ therapeutic protein, in combination with rituximab and bendamustine in relapsed indolent lymphoma patientsInvestigational New Drugs, 2014
- Comparison of two approaches for quantitative O-linked glycan analysis used in characterization of recombinant proteinsAnalytical Biochemistry, 2014
- Lectins: production and practical applicationsApplied Microbiology and Biotechnology, 2010
- Recovery of Intact 2-Aminobenzamide-Labeled O-Glycans Released from Glycoproteins by HydrazinolysisAnalytical Biochemistry, 2002